Literature DB >> 25308613

RFID in the pharmaceutical industry: addressing counterfeits with technology.

Douglas Taylor1.   

Abstract

The use of Radio Frequency Identification (RFID) in the pharmaceutical industry has grown in recent years. The technology has matured from its specialized tracking and retail uses to a systemic part of supply chain management in international pharmaceutical production and distribution. Counterfeit drugs, however, remain a significant challenge for governments, pharmaceutical companies, clinicians, and patients and the use of RFID to track these compounds represents an opportunity for development. This paper discusses the medical, technological, and economic factors that support widespread adoption of RFID technology in the pharmaceutical industry in an effort to prevent counterfeit medicines from harming patients and brand equity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25308613     DOI: 10.1007/s10916-014-0141-y

Source DB:  PubMed          Journal:  J Med Syst        ISSN: 0148-5598            Impact factor:   4.460


  12 in total

1.  Growing threat from counterfeit medicines.

Authors: 
Journal:  Bull World Health Organ       Date:  2010-04       Impact factor: 9.408

Review 2.  The adoption and implementation of RFID technologies in healthcare: a literature review.

Authors:  Wen Yao; Chao-Hsien Chu; Zang Li
Journal:  J Med Syst       Date:  2011-10-19       Impact factor: 4.460

3.  Adding intelligence to mobile asset management in hospitals: the true value of RFID.

Authors:  Linda Castro; Elisabeth Lefebvre; Louis A Lefebvre
Journal:  J Med Syst       Date:  2013-08-13       Impact factor: 4.460

Review 4.  Impact of radio-frequency identification (RFID) technologies on the hospital supply chain: a literature review.

Authors:  Alberto Coustasse; Shane Tomblin; Chelsea Slack
Journal:  Perspect Health Inf Manag       Date:  2013-10-01

5.  Economic analysis of use of counterfeit drugs: health impairment risk of counterfeit phosphodiesterase type 5 inhibitor taken as an example.

Authors:  Minoru Sugita; Michiko Miyakawa
Journal:  Environ Health Prev Med       Date:  2010-02-09       Impact factor: 3.674

6.  Outbreak of adverse reactions associated with contaminated heparin.

Authors:  David B Blossom; Alexander J Kallen; Priti R Patel; Alexis Elward; Luke Robinson; Ganpan Gao; Robert Langer; Kiran M Perkins; Jennifer L Jaeger; Katie M Kurkjian; Marilyn Jones; Sarah F Schillie; Nadine Shehab; Daniel Ketterer; Ganesh Venkataraman; Takashi Kei Kishimoto; Zachary Shriver; Ann W McMahon; K Frank Austen; Steven Kozlowski; Arjun Srinivasan; George Turabelidze; Carolyn V Gould; Matthew J Arduino; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-12-03       Impact factor: 91.245

7.  Outbreak of acute renal failure in Panama in 2006: a case-control study.

Authors:  E Danielle Rentz; Lauren Lewis; Oscar J Mujica; Dana B Barr; Joshua G Schier; Gayanga Weerasekera; Peter Kuklenyik; Michael McGeehin; John Osterloh; Jacob Wamsley; Washington Lum; Camilo Alleyne; Nestor Sosa; Jorge Motta; Carol Rubin
Journal:  Bull World Health Organ       Date:  2008-10       Impact factor: 9.408

8.  A review of radio frequency identification technology for the anatomic pathology or biorepository laboratory: Much promise, some progress, and more work needed.

Authors:  Jerry J Lou; Gary Andrechak; Michael Riben; William H Yong
Journal:  J Pathol Inform       Date:  2011-08-13

9.  Anticounterfeit packaging technologies.

Authors:  Ruchir Y Shah; Prajesh N Prajapati; Y K Agrawal
Journal:  J Adv Pharm Technol Res       Date:  2010-10

10.  Improving global health governance to combat counterfeit medicines: a proposal for a UNODC-WHO-Interpol trilateral mechanism.

Authors:  Tim K Mackey; Bryan A Liang
Journal:  BMC Med       Date:  2013-10-31       Impact factor: 8.775

View more
  5 in total

1.  The current and future needs of our medical systems.

Authors:  Jesse M Ehrenfeld
Journal:  J Med Syst       Date:  2015-02-01       Impact factor: 4.460

Review 2.  Falsified and Substandard Drugs: Stopping the Pandemic.

Authors:  Gaurvika M L Nayyar; Joel G Breman; Tim K Mackey; John P Clark; Mustapha Hajjou; Megan Littrell; James E Herrington
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

3.  Could the Pharmaceutical Industry Benefit from Full-Scale Adoption of Radio-Frequency Identification (RFID) Technology with New Regulations?

Authors:  Alberto Coustasse; Craig A Kimble; Robert B Stanton; Mariah Naylor
Journal:  Perspect Health Inf Manag       Date:  2016-10-01

4.  Survey of workflow and cost implications of decommissioning regarding the Falsified Medicines Directive in Hungarian hospital pharmacies.

Authors:  Péter Vajda; Katalin Richter; Zsolt Bodrogi; Robert G Vida; Lajos Botz; Sándor Kovács; Antal Zemplényi; Richárd Bella; Andras Fittler
Journal:  BMJ Open       Date:  2021-11-23       Impact factor: 3.006

5.  Counterfeit medicines in Peru: a retrospective review (1997-2014).

Authors:  Edwin Medina; Elvira Bel; Josep María Suñé
Journal:  BMJ Open       Date:  2016-04-04       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.